- Home
- PLX vs NRDY Comparison
PLX vs NRDY Comparison
Compare PLX & NRDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- NRDY
- Stock Information
- Founded
- PLX 1993
- NRDY 2007
- Country
- PLX United States
- NRDY United States
- Employees
- PLX N/A
- NRDY N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- NRDY Computer Software: Prepackaged Software
- Sector
- PLX Health Care
- NRDY Technology
- Exchange
- PLX Nasdaq
- NRDY Nasdaq
- Market Cap
- PLX 160.2M
- NRDY 188.8M
- IPO Year
- PLX 1998
- NRDY N/A
- Fundamental
- Price
- PLX $2.87
- NRDY $1.63
- Analyst Decision
- PLX Strong Buy
- NRDY Hold
- Analyst Count
- PLX 1
- NRDY 8
- Target Price
- PLX $15.00
- NRDY $1.90
- AVG Volume (30 Days)
- PLX 753.1K
- NRDY 473.9K
- Earning Date
- PLX 05-09-2025
- NRDY 05-08-2025
- Dividend Yield
- PLX N/A
- NRDY N/A
- EPS Growth
- PLX N/A
- NRDY N/A
- EPS
- PLX 0.04
- NRDY N/A
- Revenue
- PLX $53,399,000.00
- NRDY $190,231,000.00
- Revenue This Year
- PLX $65.02
- NRDY $3.83
- Revenue Next Year
- PLX $57.34
- NRDY $9.45
- P/E Ratio
- PLX $79.67
- NRDY N/A
- Revenue Growth
- PLX N/A
- NRDY N/A
- 52 Week Low
- PLX $0.82
- NRDY $0.73
- 52 Week High
- PLX $3.10
- NRDY $2.46
- Technical
- Relative Strength Index (RSI)
- PLX 56.85
- NRDY 56.15
- Support Level
- PLX $2.70
- NRDY $1.58
- Resistance Level
- PLX $2.64
- NRDY $1.69
- Average True Range (ATR)
- PLX 0.17
- NRDY 0.08
- MACD
- PLX -0.01
- NRDY 0.01
- Stochastic Oscillator
- PLX 61.67
- NRDY 68.01
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.